Be the first to like this
A collegial comparison of EpiVax’s ISPRI system compared to IEDB, in regards to immunogenicity prediction for protein therapeutics. Also, learn how EpiVax predicts clinical immunogenicity and deimmunizes proteins, using bioinformatics tools.
Want to see a video of these slides presented by world-renowned immunologist/vaccinologist, Dr. Annie De Groot, MD, CEO/CSO of EpiVax, Inc? Click this link: http://youtu.be/KnUE_YGH0JI
Contact EpiVax: http://www.epivax.com/contact/
More about ISPRI: http://bit.ly/ISPRI